We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.74%
2 Healthcare 2.42%
3 Financials 2.31%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGEN icon
12326
PUT
Precigen
PGEN
$2.18B
$83K ﹤0.01%
39,200
-6,500
-14% -$15.8K
SLND.WS icon
12327
Southland Holdings Warrants
SLND.WS
$83K ﹤0.01%
225,000
-165,425
-42% -$71.6K
WATT icon
12328
CALL
Energous
WATT
$86M
$83K ﹤0.01%
115
-170
-60% -$118K
XTKG
12329
DELISTED
X3 Holdings Co., Ltd. Class A Ordinary Shares
XTKG
0
DVLT
12330
Datavault AI
DVLT
$272M
$83K ﹤0.01%
5
-2
-29% -$36.7K
BIOSW
12331
DELISTED
BioPlus Acquisition Corp. Warrants
BIOSW
$83K ﹤0.01%
+375,000
New +$97.4K
FZT.WS
12332
DELISTED
FAST Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
FZT.WS
$83K ﹤0.01%
249,999
-125,000
-33% -$66.8K
IQMDW
12333
DELISTED
Intelligent Medicine Acquisition Corp. Warrant
IQMDW
$83K ﹤0.01%
300,000
IIIIW
12334
DELISTED
INSU Acquisition Corp. III Warrant
IIIIW
$83K ﹤0.01%
416,676
+10
+0% +$4
EQOS
12335
CALL
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$83K ﹤0.01%
36,900
+15,200
+70% +$28.9K
XELA
12336
CALL
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$83K ﹤0.01%
50
+4
+9% +$10K
SRGA
12337
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$83K ﹤0.01%
9,188
-2,463
-21% -$37.4K
CTIC
12338
PUT
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$83K ﹤0.01%
17,700
-6,600
-27% -$19.7K
QIWI
12339
DELISTED
QIWI PLC
QIWI
$83K ﹤0.01%
40,413
-93,243
-70% -$690K
HROW icon
12340
PUT
Harrow
HROW
$1.5B
$82K ﹤0.01%
+12,000
New +$92.6K
AIXC
12341
AIxCrypto Holdings Inc
AIXC
$13.7M
$82K ﹤0.01%
+249
New +$97.2K
FREE
12342
CALL
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$82K ﹤0.01%
11,400
-3,100
-21% -$27.8K
NFYS.WS
12343
DELISTED
Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFYS.WS
$82K ﹤0.01%
295,292
+942
+0.3% +$373
SCTL
12344
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$82K ﹤0.01%
45,541
-25,223
-36% -$43.7K
EQRX
12345
PUT
DELISTED
EQRx, Inc. Common Stock
EQRX
$82K ﹤0.01%
19,900
-22,700
-53% -$98.8K
ATNX
12346
DELISTED
Athenex, Inc. Common Stock
ATNX
$82K ﹤0.01%
4,978
-2,048
-29% -$40.1K
VOLT
12347
CALL
DELISTED
Volt Information Sciences, Inc.
VOLT
$82K ﹤0.01%
13,700
-9,100
-40% -$34.6K
BCLI
12348
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$81K ﹤0.01%
+1,608
New +$78.9K
GNPX icon
12349
Genprex
GNPX
$2.18M
$81K ﹤0.01%
+1
New +$97.5K
SCYX icon
12350
CALL
SCYNEXIS
SCYX
$51.5M
$81K ﹤0.01%
2,600
-1,163
-31% -$44.5K

Similar funds

Ken Griffin's Q1 2022 Portfolio in Review

As of Q1 2022, Ken Griffin held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Ken Griffin deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Ken Griffin's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Ken Griffin's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Ken Griffin fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Ken Griffin's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Ken Griffin opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Ken Griffin's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.